Comparisons of aggregate health expenditure across different countries have become popular over the last three decades as they permit a systematic investigation of the impact of different institutional regimes and other explanatory variables. Over the years, several regression analyses based on...

The aim of medical innovations is to improve health. A medical innovation can be defined as the application of new medical knowledge, often but not always embodied in a product, for example a pharmaceutical drug. Improved medical knowledge is the product of investments in medical research and/or...

This report presents a computer model for evaluating the cost-effectiveness (CE) of Hormone Replacement Therapy (HRT). The model is an extension of a previous model and includes also the risk of spine and wrist fracture. New Swedish data on risk of coronary heart disease and related mortality...

We present three types of evidence about the effect of cancer drug vintage-year of initial world launch - on cancer survival and mortality. All three are based on group-level data, and employ difference-in-difference research designs, which enable us to control for the influence of potentially...